Home › Scleroderma › District of Columbia
Scleroderma clinical trials in District of Columbia
4 studies for Scleroderma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07497087Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Washington D.C.
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- Georgetown University Medical Center - Department of Rheumatology, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.